Skip to main content
 

Genetics and genomics services at the Laboratory of Molecular Technology

Wednesday, October 26, 2011 — Poster Session III

10:00 a.m. – Noon

Natcher Conference Center

NCI

RSCHSUPP-1

Authors

  • K Banfield
  • N Bubunenko
  • S Coccodrelli
  • V Grinberg
  • T Hartley
  • S Korolevich
  • J Mitchell
  • K Pike
  • T Plona
  • A Raziuddin
  • N Shraeder
  • D Soppet
  • M Smith
  • M Spencer
  • C Stewart
  • R Stewart
  • L Su
  • Z Sun
  • J Troyer
  • X Wu

Abstract

The Laboratory of Molecular Technology (LMT) provides cutting-edge genomic expertise, tools, and analysis with a focus on quality and service. We succeed when our customers succeed and are committed to helping the National Cancer Institute and scientific community understand, treat, and eradicate both cancer and disease. Our organization offers state-of-the-art molecular tools for understanding and fighting cancer and disease. We offer competitively priced services, including Sanger sequencing, Pyrosequencing, Bisulfite sequencing, CLIA-certified mutation detection and molecular diagnostics, next-generation sequencing (Roche/454, Ion Torrent, PacBio, Illumina Whole Exome capture), array comparative genome hybridization (aCGH), quantitative PCR, transgenic genotyping, mRNA expression analysis array (primarily Affymetrix), and microRNA array services. We work with NCI researchers on a fee-for-service basis and also develop new technologies to serve the NCI intramural community.

back to top